In Case You Missed It: ACC.26 ATTR-CM Treatment Updates
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.
Add to cart failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
In Case You Missed It: ACC.26 ATTR-CM Treatment Updates
-
Narrated by:
-
Written by:
This CardiaCast episode explores the latest advances in transthyretin amyloid cardiomyopathy (ATTR-CM) presented at ACC.26, with a focused review of newly released late-stage clinical trial data for currently available disease-modifying therapies. Expert faculty Drs. Sarah Cuddy and Prem Soman break down how emerging evidence is reshaping treatment selection, including considerations for efficacy, safety, and patient-specific factors. The discussion highlights practical strategies for integrating these new findings into real-world clinical practice to optimize outcomes for patients with ATTR-CM.
This podcast is developed by the American College of Cardiology Foundation and Med-IQ and supported by an educational grant from Bridge Bio.
adbl_web_anon_alc_button_suppression_t1
No reviews yet